Given the observed clustering of obesity, hypertension, inflammation, intermittent hypoxia, hyperglycemia, and insulin and leptin resistance, studies in humans in this area are extremely difficult and require innovative experimental approaches. The gene discussed is LEP; the disease is obesity disorder.